Evidence-Based Medicine
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10501-10515
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10501
Figure 2
Figure 2 Prognostic value of SMARCA4 in patients with hepatocellular carcinoma. A: 2-year survival analysis, B: 5-year survival analysis, C: 10-year survival analysis.